Projected impact and cost-effectiveness of a rotavirus vaccination program in India, 2008

Clinical Infectious Diseases

Volumn 52, Issue 2, 2011, Pages 171-177

  Esposito, Douglas H ^a   Tate, Jacqueline E ^a   Kang, Gagandeep ^b   Parashar, Umesh D ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; CHILD; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DEATH; DISABILITY ADJUSTED LIFE YEAR; DRUG EFFICACY; HEALTH CARE; HEALTH CARE COST; HEALTH ECONOMICS; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; INDIA; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; NONHUMAN; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBLIC HEALTH; ROTAVIRUS; ROTAVIRUS INFECTION; VACCINATION;

CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; HUMANS; INDIA; INFANT; INFANT, NEWBORN; MODELS, STATISTICAL; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINATION;

EID: 79951822467     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciq094     Document Type: Article

References (24)

1. Parashar UD, Gibson CJ, Bresse JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006;12:304-306.
2. World Health Organization. Rotavirus mortality estimates. http://www.who.int/immunization-monitoring/burden/rotavirus-estimates/en/index. html. Accessed 18 November 2009.
3. Parashar UD, Burton A, Lanata C, et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009;200: S9-S15.
4. Villa S, Guiscafre H, Martinez H, Munoz O, Gutierrez G. Seasonal diarrhoeal mortality among Mexican children. Bull World Health Organ 1999;77:375-380. (Pubitemid 29269525)
5. World Health Organization. Report of the meeting on future directions for rotavirus vaccine research in developing countries. Geneva, Switzerland: World Health Organization, 2000.
6. World Health Organization. Rotavirus vaccines. Wkly Epidemiol Rec 2007;82:285-295.
7. World Health Organization. Rotavirus vaccines: an update. Wkly Epidemiol Rec 2009;84:533-540.
8. Rheingans RD, Antil L, Dreibelbis R, Podewils LJ, Bresee JS, Parashar UD. Economic costs of rotavirus gastroenteritis and costeffectiveness of vaccination in developing countries. J Infect Dis 2009;200: S16-S27.
9. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in health and medicine. New York, NY: Oxford University Press, 1996;396.
10. Murray CJL, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge, MA: Harvard University Press, 1996.
11. Tate JE, Chitambar S, Esposito DH, et al. Disease and economic burden of rotavirus diarrhoea in India. Vaccine 2009;27: F18-F24.
12. Patel M, Shane AL, Parashar UD, Jiang B, Gentsch JR, Glass RI. Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis 2009;200: S39-S48.
13. List of Member States by WHO region mortality stratum: 2003. Geneva, Switzerland: World Health Organization, 2003. http://www.who.int/whr/2003/en/ member-states-182-184-en.pdf. Accessed 17 February 2010.
14. International Institute for Population Sciences (IIPS) Macro International. 2007. National Family Health Survey (NFHS-3), 2005-2006. Vol 1. Mumbai, India: IIPS, 2007.
15. WHO/UNICEF. Review of National Immunization Coverage, 1980-2008. Available at: http://www.who.int/immunization-monitoring/data/ind.pdf. Accessed 24 November 2009.
16. GAVI. Alliance. Policy brief: GAVI Alliance new vaccine co-financing policy. Geneva, Switzerland: GAVI Alliance, 2008.
17. Accelerating the introduction of rotavirus vaccines into GAVI-eligible countries: investment case for GAVI secretariat. Seattle, WA: PATH, 2006.
18. de Oliveira LH, Danovaro-Holliday MC, Matus CR, Andrus JK. Rotavirus vaccine introduction in the Americas: progress and lessons learned. Expert Rev Vaccines 2008;7:345-353. (Pubitemid 351520022)
19. Wolfson LJ. WHO immunization coverage estimates and Trajectories (WHO ICE-T). Geneva, Switzerland: World Health Organization, 2008.
20. World Health Organization. The world health report 2002-reducing risks, promoting healthy life. Geneva, Switzerland: World Health Organization, 2002.
21. The World Bank. World development indicators data catalog: economic policy and external debt, GDP per capita. http://data.worldbank.org/indicator/ NY. GDP. PCAP. CD/countries/latest?display5default>. Accessed 9 June 2010.
22. Rose J, Hawthorn RL, Watts B, Singer ME. Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis. BMJ 2009;339: b3653.
23. Velazquez FR, Matson DO, Calva JJ, et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996;335:1022-1028. (Pubitemid 26338732)
24. Meltzer DO. Accounting for future costs in medical cost-effectiveness analysis. J Health Econ 1997;16:33-64.